Pasireotide LAR improves health-related quality of life and signs and symptoms in patients with acromegaly: Results of a 12-month randomized, double-blind, multicenter, phase III study

Authors
Category Primary study
JournalEndocrine Reviews
Year 2012
This article has no abstract
Epistemonikos ID: 30cd62bf5f16d9cc4d875bfc3cc244ab832af2c6
First added on: Feb 05, 2025